Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Cancer Research|December 21, 2017
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant ProgressionEva De Smedt, Ken Maes, Stefaan Verhulst, et al.Nature Protocols|April 17, 2021
Directed differentiation of human induced pluripotent stem cells to hepatic stellate cellsJulia Vallverdú, Raquel A Martínez García de la Torre, Inge Mannaerts, et al.Frontiers in Immunology|May 31, 2022
Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of MelanomaLien De Beck, Robin Maximilian Awad, Veronica Basso, et al.Journal of Hepatology|November 24, 2015
Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell nicheOlivier Govaere, Jasper Wouters, Michaela Petz, et al.Metabolism: Clinical and Experimental|April 23, 2023
Loss of CEACAM1 in endothelial cells causes hepatic fibrosisHarrison T Muturi, Hilda E Ghadieh, Raziyeh Abdolahipour, et al.Frontiers in Immunology|May 2, 2022
TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 ImmunotherapyKirsten De Ridder, Hanne Locy, Elisa Piccioni, et al.Scientific Reports|July 2, 2025
Loss of endothelial ZEB2 in mice attenuates steatosis early during metabolic dysfunction-associated steatotic liver diseaseWouter Dheedene, Stefaan Verhulst, Louise Demuynck, et al.Gastroenterology|October 31, 2020
Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and CholestasisElisabeth Verboven, Iván M Moya, Leticia Sansores-Garcia, et al.Molecular Metabolism|August 21, 2024
Conditional deletion of CEACAM1 in hepatic stellate cells causes their activationHarrison T Muturi, Hilda E Ghadieh, Suman Asalla, et al.Science (New York, N.Y.)|November 23, 2019
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in miceIván M Moya, Stéphanie A Castaldo, Laura Van den Mooter, et al.Pageof 6